News Daily News SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide Michael O'Riordan December 18, 2025
News Daily News Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis Yael L. Maxwell October 24, 2025
News Daily News AI-Supported Coaching Shows Promise for Improving Glycemic Control L.A. McKeown August 25, 2025
News Daily News PRAGUE-25: Ablation Improves Rhythm Control, but Don’t Discount Lifestyle Changes Todd Neale July 14, 2025
News Daily News Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC Michael O'Riordan June 25, 2025
News Daily News Weight-Loss Drug MariTide Gains Momentum in Phase II Trial Caitlin E. Cox June 25, 2025
News Conference News European Congress on Obesity 2025 SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly Michael O'Riordan May 14, 2025
News Conference News European Congress on Obesity 2025 Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5 Michael O'Riordan May 12, 2025
News Daily News Weekend Warriors Also See Mortality Benefits With Exercise Michael O'Riordan April 10, 2025
News Conference News THT 2025 Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity Todd Neale February 12, 2025
News Daily News Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review Todd Neale January 09, 2025
News Daily News FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity L.A. McKeown December 13, 2024
News Conference News EACTS 2024 Will Semaglutide Change Cardiac Surgery? It Already Has Yael L. Maxwell October 10, 2024
News Daily News Time-Restricted Eating Tightens Glycemic Control in Patients With Metabolic Syndrome Caitlin E. Cox October 04, 2024
News Daily News Liraglutide Helps Shed Weight in Young Children With Obesity Todd Neale September 13, 2024